Search Result "5-HT<sub>2C</sub>."
Atypical antipsychotics and inverse agonism at 5-HT2 receptors
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3732-3738
Author(s): Laura C. Sullivan,William P Clarke,Kelly A. Berg
Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 1723-1740
Author(s): Katarzyna Panczyk, Sylwia Go lda, Anna Waszkielewicz, Dorota Zelaszczyk, Agnieszka Gunia-Krzyz ak, Henryk Marona
Serotonin2c Receptor Constitutive Activity: In vivo Direct and Indirect Evidence and Functional Significance
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 98-107
Author(s): Sylvia Navailles,Mélanie Lagière,Martin Guthrie,Philippe De Deurwaerdère
Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 6 Year: 2013 Page: 861-869
Author(s): Saki Shimizu, Yuto Mizuguchi, Yukihiro Ohno
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 11 Year: 2017 Page: 928-938
Author(s): Carlos M. Villalón,Antoinette Maassen VanDenBrink
Determining the Oligomer Number of Native GPCR Using Florescence Correlation Spectroscopy and Drug-Induced Inactivation-Reactivation
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 10 Year: 2014 Page: 927-937
Author(s): Milt Teitler,Katharine Herrick-Davis
Lorcaserin: Worthy of Further Insights? Results from Recent Research
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 23 Issue: 3 Year: 2024 Page: 278-283
Author(s): Georgios D. Kotzalidis
Design, Synthesis and Anticancer Evaluation of New 1-allyl-4-oxo-6-(3,4,5-trimethoxyphenyl)-1,4-dihydropyrimidine-5-carbonitrile Bearing PyrazoleMoieties
Journal: Current Organic Synthesis
Volume: 20 Issue: 8 Year: 2023 Page: 897-909
Author(s): Nermine A. Osman,Nermine S. EL-Sayed,Hanan A. Abdel Fattah,Ahmad J. Almalki,Ahmed K. Kammoun,Tarek S. Ibrahim,Abdulrahman S. Alharbi,Amany M. AL-Mahmoudy
Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
Journal: Current Neuropharmacology
Volume: 12 Issue: 5 Year: 2014 Page: 387-398
Author(s): Maximilian Gahr
Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1086-1101
Author(s): Rüdiger Hardeland